Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.635
-0.025 (-1.51%)
Apr 29, 2026, 9:42 AM EDT - Market open
Lexicon Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -50.34 | -200.4 | -177.12 | -101.94 | -87.76 | Upgrade
|
| Depreciation & Amortization | 0.62 | 0.53 | 0.55 | 0.43 | 0.29 | Upgrade
|
| Other Amortization | 1.7 | 1.85 | 1.77 | 0.74 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.71 | -9.31 | -5.62 | - | - | Upgrade
|
| Stock-Based Compensation | 12.52 | 13.5 | 14.34 | 11.52 | 10.58 | Upgrade
|
| Other Operating Activities | -1.74 | 0.81 | 1.51 | - | - | Upgrade
|
| Change in Accounts Receivable | 1.09 | -2.46 | -0.98 | -0.01 | 0.38 | Upgrade
|
| Change in Inventory | -0.05 | 0.15 | -0.38 | - | - | Upgrade
|
| Change in Accounts Payable | -30.22 | 14.8 | 6.45 | 0.08 | -14.16 | Upgrade
|
| Change in Other Net Operating Assets | 2.29 | 1.75 | -2.43 | 0.34 | 3.55 | Upgrade
|
| Operating Cash Flow | -67.85 | -178.78 | -161.9 | -88.85 | -87.02 | Upgrade
|
| Capital Expenditures | - | -1.03 | -0.47 | -1.33 | -1.22 | Upgrade
|
| Investment in Securities | 113.02 | -14.35 | -49.47 | -69.75 | 3.33 | Upgrade
|
| Investing Cash Flow | 113.02 | -15.38 | -49.94 | -71.08 | 2.11 | Upgrade
|
| Long-Term Debt Issued | - | - | 49.96 | 48.87 | - | Upgrade
|
| Long-Term Debt Repaid | -48 | - | - | - | -11.7 | Upgrade
|
| Net Debt Issued (Repaid) | -48 | - | 49.96 | 48.87 | -11.7 | Upgrade
|
| Issuance of Common Stock | 0.07 | 0.06 | 138.82 | 94.21 | 37.08 | Upgrade
|
| Repurchase of Common Stock | -0.57 | -1.73 | -0.82 | -0.86 | -2.68 | Upgrade
|
| Other Financing Activities | - | -1.31 | - | - | - | Upgrade
|
| Financing Cash Flow | -48.5 | 238.35 | 187.96 | 142.21 | 22.71 | Upgrade
|
| Net Cash Flow | -3.33 | 44.19 | -23.88 | -17.72 | -62.2 | Upgrade
|
| Free Cash Flow | -67.85 | -179.81 | -162.37 | -90.18 | -88.24 | Upgrade
|
| Free Cash Flow Margin | -136.24% | -578.52% | -13485.63% | -64875.54% | -29610.07% | Upgrade
|
| Free Cash Flow Per Share | -0.19 | -0.56 | -0.73 | -0.54 | -0.61 | Upgrade
|
| Cash Interest Paid | 8.33 | 12.92 | 10.06 | 2.29 | 0.8 | Upgrade
|
| Levered Free Cash Flow | -47.82 | -105.3 | -94.97 | -52.65 | -55.54 | Upgrade
|
| Unlevered Free Cash Flow | -44.3 | -97.41 | -88.56 | -51.65 | -55.09 | Upgrade
|
| Change in Working Capital | -26.89 | 14.24 | 2.66 | 0.4 | -10.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.